1,924 findings · Energy balance · published 2022+
- Energy balanceGood
In patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), achieving a baseline Body Mass Index (BMI) of 30 kg/m² or higher is a significant independent predictor of achieving clinically relevant weight loss (≥7% of initial body weight) through lifestyle interventions.
If you have MASLD and a BMI of 30 or higher, you are statistically more likely to achieve significant weight loss through lifestyle changes than someone with a lower BMI. This is likely due to higher energy expenditure at rest. Use this advantage by committing to the lifestyle changes early, as your body is primed to respond to caloric deficits more robustly than those with lower baseline weights.
Supports 2025New - Energy balanceGood
Achieving a 5% weight loss over one year results in substantial direct medical cost savings for people with obesity, with savings increasing alongside higher obesity severity.
You do not need to achieve massive weight loss to see financial benefits. Losing just 5% of your body weight within a year can lead to substantial savings in direct medical costs, with the greatest savings seen in those with higher obesity severity (Class II and III). Focus on achieving this modest, sustainable reduction.
Supports 2025New - Energy balanceGood
Sustained weight loss of at least 10% from maximum weight is recommended for adults with overweight or obesity at moderate or high ASCVD risk to reduce cardiovascular events.
If you are at moderate or high cardiovascular risk, aim to lose 10% of your maximum lifetime weight. This is a higher bar than the 5% target for lower-risk individuals, but it is the threshold shown to significantly reduce the risk of heart attacks and strokes. Discuss with your doctor if pharmacotherapy (like GLP-1s) or surgery is appropriate to help you reach this target.
Qualifies 2025New - Energy balanceGood
Lifestyle interventions, specifically achieving 7-10% body weight loss through caloric restriction and physical activity, are the cornerstone for reducing cardiovascular risk and improving hepatic steatosis in patients with metabolic-associated steatotic liver disease (MASLD).
To lower your heart and liver risk, aim to lose 7-10% of your body weight through a calorie-controlled diet (cut 500-1000 calories daily) and regular exercise (150 minutes of moderate activity weekly). Prioritize whole grains, lean proteins, and healthy fats (Mediterranean style), while eliminating sugary drinks and trans fats. Stop drinking alcohol completely, as it harms the liver more than it helps the heart in this condition. Work with a healthcare team to make these changes sustainable.
Supports 2025New - Energy balanceGood
Long-term maintenance of weight loss requires significantly higher physical activity levels (≥150–250 minutes/week) than those recommended for general health or initial weight loss.
To keep weight off, you need to move significantly more than the standard '150 minutes a week' recommendation. Aim for at least 4 hours of moderate activity (like brisk walking) per week. This higher volume is necessary to counteract your body's natural tendency to regain weight after you've lost it.
Supports 2023 - Energy balanceGood
Low Energy Availability (LEA) negatively impacts performance and health in both male and female athletes, causing reduced explosive power, endurance, and increased risk of injury and hormonal dysfunction.
Ensure your energy intake matches your expenditure. For both men and women, consuming too few calories relative to activity levels reduces strength, endurance, and increases injury risk. Monitor energy availability, aiming for >45 kcal/kg fat-free mass for healthy adults.
Supports 2023 - Energy balanceGood
A daily caloric deficit of 500-1,000 kcal combined with personalized dietary composition (high fiber, low refined carbs) induces a sustainable weight loss of 2-4 kg per month while preserving muscle mass and basal metabolic rate.
To lose weight sustainably, create a daily deficit of 500 to 1,000 calories by eating slightly less and moving slightly more. Aim for 2-4 kg of loss per month. Prioritize whole grains, vegetables, and fiber while cutting refined carbs and sugary drinks. This moderate pace protects your muscle and metabolism, making it easier to keep the weight off long-term.
Supports 2024 - Energy balanceGood
Non-pharmacological lifestyle interventions (caloric deficit >500 kcal/day, physical activity >200 min/week) can achieve up to 8% mean weight loss over 6 months, comparable to moderate-efficacy anti-obesity medications.
Start with a 500 kcal daily deficit and aim for over 200 minutes of physical activity per week. This can yield up to 8% weight loss in 6 months, matching moderate drugs, but requires long-term adherence to prevent regain.
Supports 2024 - Energy balanceGood
Endoscopic Sleeve Gastroplasty (ESG) achieves 16-20% total weight loss at 12 months and improves metabolic markers without worsening GERD.
ESG is a minimally invasive procedure that reduces stomach size by 70-80% using sutures. It achieves 16-20% weight loss at one year and improves blood pressure and diabetes markers. Unlike some surgeries, it does not typically worsen acid reflux. It is suitable for those with a BMI of 30-50 who want a less invasive option than traditional surgery.
Supports 2024 - Energy balanceGood
Significant weight loss (≥15% body weight) achieved through intensive dietary intervention can induce remission of type 2 diabetes in a majority of patients.
To potentially reverse Type 2 Diabetes, you must lose a significant amount of weight—specifically 15% or more of your body weight. This usually requires a structured, intensive dietary intervention (like total diet replacement) under medical supervision, not just 'eating less'. The goal is to remove fat from your liver and pancreas to restore their normal function.
Supports 2025New - Energy balanceGood
During caloric restriction, higher protein intake (2.3–3.1 g/kg of fat-free mass) helps preserve lean body mass and reduces fat mass.
If you are cutting calories to lose fat, increase your protein to 2.3–3.1 grams per kilogram of your fat-free mass (or total body weight if you don't know your FFM) to protect your muscle.
Supports 2023 - Energy balanceGood
A weight gain of ≥5% over a 3-year period significantly increases the risk of incident type 2 diabetes, while a weight loss of ≥5% significantly decreases it, independent of attained weight.
To lower your risk of type 2 diabetes, aim for a weight change of at least 5% of your body weight over a few years. Losing 5% or more significantly reduces your risk, while gaining 5% or more significantly increases it. This benefit exists regardless of your final weight, meaning the act of changing your weight matters for your metabolic health.
Supports 2024 - Energy balanceGood
Aggressive weight loss management is the primary first step for treating type 2 diabetes, as diet can effectively lead to remission through progressively greater degrees of weight loss improving insulin sensitivity.
If you have recently been diagnosed with type 2 diabetes, focus on losing weight through diet as your first priority. The more weight you lose, the better your insulin sensitivity becomes, and this can lead to remission of the disease.
Supports 2024 - Energy balanceGood
Weight loss achieved through caloric restriction, exercise, or bariatric surgery reduces the Apnea-Hypopnea Index (AHI) in patients with Obstructive Sleep Apnea (OSA) and Obesity Hypoventilation Syndrome (OHS), with the magnitude of AHI reduction correlating non-linearly with the percentage of BMI reduction.
Losing weight is one of the most effective ways to reduce the severity of sleep apnea. You do not need to reach a 'perfect' weight to see benefits; even a 10% reduction in body weight can significantly lower the number of breathing interruptions during sleep. If lifestyle changes (diet and exercise) do not show improvement in your sleep metrics within 3 months, consult your doctor about escalating to pharmacotherapy (like GLP-1 agonists) or bariatric surgery, which can induce remission in many cases.
Supports 2025New - Energy balanceGood
Physical activity, particularly resistance and mixed exercise, reduces visceral adipose tissue more effectively than caloric restriction alone.
If your goal is to reduce dangerous visceral fat, prioritize exercise over strict dieting. Exercise has a stronger effect on reducing visceral fat than caloric restriction alone. Combine this with a healthy diet for best overall results.
Supports 2024 - Energy balanceGood
High consumption of ultra-processed foods increases the risk of overweight and obesity in adults.
Reduce your intake of ultra-processed foods (items with many industrial ingredients, additives, and low whole food content). Focus on replacing them with minimally processed foods. This change is associated with a significant reduction in the risk of gaining excess weight and developing obesity.
Supports 2023 - Energy balanceGood
Achieving 5-10% weight loss through any method (including medication) is associated with significant improvements in obesity-related comorbidities, including type 2 diabetes prevention, cardiovascular risk reduction, and NAFLD resolution.
You do not need to lose a massive amount of weight to see health improvements. Losing just 5-10% of your body weight can significantly reduce your risk of type 2 diabetes, heart disease, and other obesity-related conditions. Focus on this achievable goal.
Supports 2025New - Energy balanceGood
Laparoscopic sleeve gastrectomy (LSG) provides 60–70% excess weight loss and 50–60% type 2 diabetes remission at 5–7 years, with efficacy comparable to Roux-en-Y gastric bypass (RYGB) and superior safety for super-obese patients (BMI > 60).
Sleeve gastrectomy is currently the most common and effective surgical option for severe obesity, offering significant long-term weight loss and diabetes remission rates comparable to more complex bypass surgeries, with a strong safety profile especially for patients with very high BMI.
Supports 2025New - Energy balanceGood
Lifestyle modifications, specifically calorie restriction of 500-750 kcal/day and ≥ 150 minutes of exercise per week, are the first-line treatment for obesity, though long-term maintenance is challenging without pharmacological or surgical support.
Start with a daily calorie deficit of 500-750 kcal and aim for at least 150 minutes of exercise per week. This is the first step in managing obesity. Remember, long-term success is often about finding a sustainable lifestyle you can stick to, rather than a specific 'magic' diet.
Qualifies 2026New - Energy balanceGood
Intragastric balloons (Obalon, Orbera, ReShape Duo) provide temporary weight loss (12-25% EWL) when combined with lifestyle modifications.
Intragastric balloons are temporary devices placed in the stomach to help with weight loss. They work by taking up space, making you feel full sooner. Clinical trials show they can lead to 12-25% excess weight loss when combined with lifestyle changes, significantly outperforming lifestyle changes alone. They require an endoscopic procedure and are typically removed after 6 months.
Supports 2025New - Energy balanceGood
Lifestyle interventions involving ≥150 minutes of exercise per week combined with caloric restriction are associated with the highest odds of long-term weight loss maintenance (5-10%).
To keep weight off long-term, aim for at least 150 minutes of exercise per week, ideally closer to 275 minutes, while maintaining a healthy diet. This combination offers the best chance of keeping 5-10% of your weight off permanently.
Supports 2026New - Energy balanceGood
The median total weight loss percentage after eight weeks was 10.2%.
Practitioners can expect an average weight loss of around 10% in similar programs.
Supports 2023 - Energy balanceGood
Current cardiovascular guidelines emphasize lifestyle modifications for weight loss.
Clinicians should incorporate lifestyle changes as a primary strategy for weight loss.
Supports 2023 - Energy balanceGood
Post-menopausal females should ingest at least the RDA of 0.8 g·kg−1·d−1 of protein.
Practitioners should recommend a minimum protein intake of 0.8 g·kg−1·d−1 for post-menopausal women.
Supports 2024